Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-14

FDA Approved: LATANOPROST — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approved latanoprost from Micro Labs Limited through an original application; indicated to reduce intraocular pressure in open-angle glaucoma or ocular hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

ORIG AP for LATANOPROST (LATANOPROST)